Patent details

EP3914247 Title: USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE

Basic Information

Publication number:
EP3914247
PCT Application Number:
US2020014531
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207082835
PCT Publication Number:
WO2020154354
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE
French Title of Invention:
UTILISATION DE MIGALOSTAT POUR RÉDUIRE LE RISQUE D'ACCIDENT VASCULAIRE CÉRÉBRAL CHEZ LES PATIENTS SOUFFRANT DE LA MALADIE DE FABRY
German Title of Invention:
VERWENDUNG VON MIGALOSTAT ZUR VERRINGERUNG DES RISIKOS DES ZEREBROVASKULÄREN EREIGNISSES BEI PATIENTEN MIT FABRY-KRANKHEIT
SPC Number:

Dates

Filing date:
22/01/2020
Grant date:
13/11/2024
EP Publication Date:
01/12/2021
PCT Publication Date:
30/07/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/11/2024
EP B1 Publication Date:
13/11/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/01/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/11/2024
 
 

Name:
Amicus Therapeutics, Inc.
Address:
3675 Market Street, Philadelphia, PA 19104, United States (US)

Agent

Name:
ARONOVA S.A.
From:
23/01/2025
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
LAGAST, Hjalmar
Address:
United States (US)

2

Name:
SKUBAN, Nina
Address:
United States (US)

Priority

Priority Number:
201962795524 P
Priority Date:
22/01/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/445; A61P 9/00; A61P 25/00;

Publication

European Patent Bulletin

1

Issue number:
202446
Publication date:
13/11/2024
Description:
Grant (B1)

2

Issue number:
202451
Publication date:
18/12/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/01/2025 Power Of Attorney 1
23/01/2025 Outgoing Correspondence 1